LATIN AMERICA IMMUNOGLOBULIN MARKET 2022-2028

Lifesciences | Diagnostic & Biotechnology

LATIN AMERICA IMMUNOGLOBULIN MARKET 2022-2028

Market by Type, Delivery Mode, Application, End-user, Sales Channel, and Country Outlook | Forecast 2022-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s analysis, Latin America’s immunoglobulin market is likely to develop with a CAGR of 5.29% over the forecasting years 2022-2028.


Report scope can be customized per your requirements. Request For Customization

The countries analyzed in this region include:

•         Mexico

•         Brazil

•         Rest of Latin America

The immunoglobulin market in Latin America is expected to bolster due to the presence of market leaders, such as Pfizer. Moreover, the region focuses on bringing innovation through product developments and launches along with significant investments and growth in biotechnology and pharmaceuticals. Besides, the support from the government in product approvals has also contributed to the growth of the studied market.

Brazil witnessed a boost in the immunoglobulin market because of strategic initiatives by the top players in developing products. In addition to this, the increase in product approvals by the government is likely to have a positive impact on the overall market’s growth. For instance, The Brazilian Health Regulatory Agency has approved Celltrion Healthcare’s regdanvimab for emergency use. It is a monoclonal antibody treatment for patients with mild-to-moderate COVID-19.

Additionally, in 2019, SK Plasma won a bid of $20 million to supply LIV-Gamma to Brazil’s Ministry of Health. It helps reduce the risk of infection in patients with poor immune systems and those suffering from chronic lymphocytic leukemia, bone marrow transplantation, etc. Such developments in the country’s biotech and pharma industry are augmenting the market’s growth process.

On the other hand, Argentina showcased significant developments in the immunoglobulin market, which is anticipated to open new avenues. For instance, Scientists at the Leloir Institute Foundation and CONICET launched a new serological test for COVID-19 called COVIDAR IgM. It helps detect IgM immunoglobulin, the first antibody produced by the immune system to fight infection. Likewise, in 2020, mAbxience set up a new biosimilar monoclonal antibody plant in the country, and these drugs are used in treating oncological and autoimmune diseases such as rheumatoid arthritis. Thus, all these factors are fostering the growth of the immunoglobulin market in the country.

Intramuscular immunoglobulin is commonly used for hyperimmune globulins such as rabies immune globulin. Here, the intramuscular immune globulin aids in the short-term prevention of specific infectious diseases such as hepatitis A through a single dose. It also offers a combined or independent therapeutic treatment option for recalcitrant suppurative skin diseases such as hidradenitis, decalvans, suppurativa, or chronic recurrent furunculosis.

The studied report evaluates the market’s growth based on the delivery mode, application, end-user, sales channel, and type. Here, the delivery mode segment contains intravenous, intramuscular, and subcutaneous.

The leading players considered in the immunoglobulin market include ADMA Biologics, Bio Products Laboratory, China Biologic Products Inc, Pfizer Inc, Kedrion Biopharma, Takeda Pharmaceutical Company Limited, Grifols SA, and Shanghai RAAS Blood Products Co Ltd.

Bio Products Laboratory is a company involved in the manufacturing of human blood plasma products. The company has plasma collection centers and is dedicated to producing various medicines to treat immune deficiencies, bleeding disorders, infectious diseases, and critical care. Moreover, it operates under two divisions, BPL Therapeutics and BPL Plasma. In 2021, the company invested $31 million in a new Sterile Filing Suite, a 1,000 square meter state-of-the-art suite that aims at supporting plasma-derived medicinal products. Besides, the company has its presence in over 50 countries globally and was founded in 1954.

 

Key deliverables of the report:

·  Market CAGR during the forecasting years 2022-2028

·  Detailed data highlighting key insights, industry components, and market strategies

· Comprehensive information and estimation of the immunoglobulin market revenue growth in Latin America and its influence on the parent market 

·  In-depth study of forthcoming trends in consumer behavioral patterns

·  A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces Model

· A wide-ranging study of factors that will challenge the Latin America immunoglobulin market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. LATIN AMERICA IMMUNOGLOBULIN MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE IMMUNOGLOBULIN MARKET

2.2. KEY INSIGHTS

2.2.1. DEVELOPMENT OF NEW PURIFICATION METHODS

2.2.2. INCREASING PREFERENCE FOR PERSONALIZED MEDICINES

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1. PRODUCT LAUNCHES & DEVELOPMENTS

2.6.2. PARTNERSHIPS & AGREEMENTS

2.7. MARKET DRIVERS

2.7.1. GROWTH IN THE GERIATRIC POPULATION

2.7.2. PREVALENCE OF IMMUNODEFICIENCY DISEASES AND AUTOIMMUNE DISORDERS

2.7.3. INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES

2.8. MARKET CHALLENGES

2.8.1. HIGH COST OF THERAPY

2.8.2. HIGH RISK OF SIDE EFFECTS DUE TO THE USE OF IMMUNOGLOBULIN

2.9. MARKET OPPORTUNITIES

2.9.1. INCREASING ADOPTION OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) TREATMENTS

2.9.2. GROWING CLINICAL TRIALS

3. LATIN AMERICA IMMUNOGLOBULIN MARKET OUTLOOK – BY TYPE

3.1. IGG

3.2. IGA

3.3. IGM

3.4. IGE

3.5. IGD

4. LATIN AMERICA IMMUNOGLOBULIN MARKET OUTLOOK – BY DELIVERY MODE

4.1. INTRAVENOUS

4.2. SUBCUTANEOUS

4.3. INTRAMUSCULAR

5. LATIN AMERICA IMMUNOGLOBULIN MARKET OUTLOOK – BY APPLICATION

5.1. HYPOGAMMA GLOBULINEMIA

5.2. CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY

5.3. PRIMARY IMMUNODEFICIENCY DISEASES

5.4. MYASTHENIA GRAVIS

5.5. MULTIFOCAL MOTOR NEUROPATHY

5.6. IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

5.7. INFLAMMATORY MYOPATHIES

5.8. SPECIFIC ANTIBODY DEFICIENCY

5.9. GUILLAIN-BARRE SYNDROME

5.10. OTHER APPLICATIONS

6. LATIN AMERICA IMMUNOGLOBULIN MARKET OUTLOOK – BY END-USER

6.1. HOSPITALS & CLINICS

6.2. HOMECARE

7. LATIN AMERICA IMMUNOGLOBULIN MARKET OUTLOOK – BY SALES CHANNEL

7.1. HOSPITAL PHARMACY

7.2. SPECIALTY PHARMACY

7.3. OTHER SALES CHANNELS

8. LATIN AMERICA IMMUNOGLOBULIN MARKET – COUNTRY OUTLOOK

8.1. BRAZIL

8.2. MEXICO

8.3. REST OF LATIN AMERICA

9. COMPETITIVE LANDSCAPE

9.1. BIOTEST AG

9.2. CHINA BIOLOGIC PRODUCTS INC

9.3. GRIFOLS SA

9.4. LFB GROUP

9.5. CSL BEHRING

9.6. KEDRION BIOPHARMA

9.7. OCTAPHARMA AG

9.8. TAKEDA PHARMACEUTICAL COMPANY LIMITED

9.9. BIO PRODUCTS LABORATORY

9.10. SHANGHAI RAAS BLOOD PRODUCTS CO LTD

9.11. PFIZER INC

9.12. SANQUIN PLASMA PRODUCTS BV

9.13. ADMA BIOLOGICS

9.14. SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO LTD

9.15. KAMADA LTD

10. RESEARCH METHODOLOGY & SCOPE

10.1. RESEARCH SCOPE & DELIVERABLES

10.2. SOURCES OF DATA

10.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY TYPE, 2022-2028 (IN $ MILLION)

TABLE 4: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY DELIVERY MODE, 2022-2028 (IN $ MILLION)

TABLE 5: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)

TABLE 6: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

TABLE 7: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY SALES CHANNEL, 2022-2028 (IN $ MILLION)

TABLE 8: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY TYPE, 2021 & 2028 (IN %)

FIGURE 3: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY IGG, 2022-2028 (IN $ MILLION)

FIGURE 4: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY IGA, 2022-2028 (IN $ MILLION)

FIGURE 5: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY IGM, 2022-2028 (IN $ MILLION)

FIGURE 6: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY IGE, 2022-2028 (IN $ MILLION)

FIGURE 7: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY IGD, 2022-2028 (IN $ MILLION)

FIGURE 8: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY DELIVERY MODE, 2021 & 2028 (IN %)

FIGURE 9: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY INTRAVENOUS, 2022-2028 (IN $ MILLION)

FIGURE 10: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY SUBCUTANEOUS, 2022-2028 (IN $ MILLION)

FIGURE 11: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY INTRAMUSCULAR, 2022-2028 (IN $ MILLION)

FIGURE 12: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY APPLICATION, 2021 & 2028 (IN %)

FIGURE 13: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY HYPOGAMMA GLOBULINEMIA, 2022-2028 (IN $ MILLION)

FIGURE 14: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, 2022-2028 (IN $ MILLION)

FIGURE 15: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY PRIMARY IMMUNODEFICIENCY DISEASES, 2022-2028 (IN $ MILLION)

FIGURE 16: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY MYASTHENIA GRAVIS, 2022-2028 (IN $ MILLION)

FIGURE 17: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY MULTIFOCAL MOTOR NEUROPATHY, 2022-2028 (IN $ MILLION)

FIGURE 18: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), 2022-2028 (IN $ MILLION)

FIGURE 19: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY INFLAMMATORY MYOPATHIES, 2022-2028 (IN $ MILLION)

FIGURE 20: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY SPECIFIC ANTIBODY DEFICIENCY, 2022-2028 (IN $ MILLION)

FIGURE 21: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY GUILLAIN-BARRE SYNDROME, 2022-2028 (IN $ MILLION)

FIGURE 22: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)

FIGURE 23: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY END-USER, 2021 & 2028 (IN %)

FIGURE 24: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY HOSPITALS & CLINICS, 2022-2028 (IN $ MILLION)

FIGURE 25: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY HOMECARE, 2022-2028 (IN $ MILLION)

FIGURE 26: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY SALES CHANNEL, 2021 & 2028 (IN %)

FIGURE 27: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY HOSPITAL PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 28: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY SPECIALTY PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 29: LATIN AMERICA IMMUNOGLOBULIN MARKET, BY OTHER SALES CHANNELS, 2022-2028 (IN $ MILLION)

FIGURE 30: LATIN AMERICA IMMUNOGLOBULIN MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 31: BRAZIL IMMUNOGLOBULIN MARKET 2022-2028 (IN $ MILLION)

FIGURE 32: MEXICO IMMUNOGLOBULIN MARKET 2022-2028 (IN $ MILLION)

FIGURE 33: REST OF LATIN AMERICA IMMUNOGLOBULIN MARKET 2022-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;